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ABSTRACT
One of the numerous responsibilities of the government 
of any country is to invest in the various sectors of the 
economy. This should, however, be channeled to the ap-
propriate sectors, such as the health sector, that will lead 
to a continual growth of the country. It is in the light 
of this, that this study looks at government spending on 
the health sector and its effect on infant mortality rate 
(INFM) in Nigeria. Health is central to the well-being 
of the citizens. This study made an attempt to provide 
empirical evidence of the impact of public health ex-
penditure on infant mortality rate in Nigeria between 
1991 and 2018 using time series data. The Fully Modi-
fied Ordinary Least Square (FMOLS) analytical method 
was used to examine the relationships. Various robust-
ness checks were carried out to ensure the reliability of 
the result for policy makers. Findings revealed that all 
variables employed positively impacted INFM except 
for Diphtheria, Pertussis, and Tetanus (DPT) immuni-
zation and female literacy rate. It was therefore recom-
mended that more public enlightenments on the impor-
tance of taking DPT immunization for infants should 
be embarked upon for the target audience to be able to 
produce a positive effect, nursing mothers should be ed-
ucated more on the need to take good care of their chil-
dren especially at the early stage and not leave chance to 
the faith of the day care, all in the name of being literate 
and answering the call of their job at the expense of their 
parental role among others.
© 2020 ACE. All rights reserved
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1. INTRODUCTION
Health, a very important aspect of an individual’s wellbeing, is one of the indis-
pensable necessary conditions for achieving a sustainable long-term economic 
development. It has been established in the literature that improvement in health 
care is an important prerequisite for enhancing Human Capital Development in 
every economy. Siddiqui, Afridi and Haq (1995) are of the opinion that improved 
health status of a nation creates outward shift in labour supply curve which im-
plied increased productivity of labour with a resultant increase in the productiv-
ity of investment in other forms of human capital. Thus, the level of government 
expenditure on health determines the ultimate level of human capital develop-
ment which eventually leads to better, more skillful, efficient and productive 
investment in other sectors of the economy (Muhammad & Khan, 2007). 
To this end, provision of good health has been seen by many governments as a 
key element of any policy aimed at promoting a broad based economic growth. 
Mocan, Tekin and Zax (2004) also affirm that good health is a crucial part of 
well-being and a key of social and economic development. In contrast, poor 
health can be detrimental to the welfare and development of a country. Good 
health is not only basic to human welfare but also to social and economic de-
velopment. Poor health shackles human capital, reduces returns on learning, im-
pedes entrepreneurial activities as well as growth and development of a nation. 
Consequently, it has become a focused policy by governments at all levels. 
Without doubt, an increased proportion of the nation’s resources is today being 
spent on health and medical care value as it was nearly six decades ago. This 
perhaps is in recognition of the importance of health which of course has also 
been recognized as a multi sectorial responsibility inseparably linked to a nation 
socio-economic development. 
In recent years, improvement in the health condition of people has been the focus 
of policy makers. Children, especially infants, are the most vulnerable group in 
the society. While some children escape childhood killer diseases such as mea-
sles and diphtheria and transit into adulthood, others die before their first birth-
day. Those who are fortunate to survive the first twelve months are likely to die 
even before reaching age five. Reducing mortality rate among children therefore 
is a major way of improving health status and welfare of children as well as se-
curing healthy future workforce for the nation.
In line with the above, UNDP (1990) and World Bank (1993) have recognized 
the public provision of health care services as one of the important ways to im-
prove living conditions and human welfare of a nation. To this end, Nigerian 
government has taken different measures at reducing children mortality rate hav-
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ing known the peculiarity of the country’s parents. One of such measures is a 
random house to house immunization for children at intervals, and yet the mor-
tality rate is still high compared to other developing nations of the world.
In addition, it is usual to find long queues of patients in Nigeria public hospitals 
waiting patiently for medical attention despite the fact that the nation has, over 
the years, made steady progress in terms of improved quality and quantity of 
medical manpower and health facilities. For instance, despite Nigeria’s rapid 
population growth, there has been a tremendous decrease in the nation’s popula-
tion per health resources from 47,330 in 1960 to 6,200 in 1986 per doctor which 
still decreases to 4,222 patients or 2.27 per 10,000 people as in 2018 all of which 
is above WHO consideration of one doctor per 600 people in a country (Chris 
Ngige, Channels television, April, 26, 2019, IndexMundi). 
In spite of the above achievement however, a high percentage of infant in Nige-
ria above the MDGs target still die before their first year. The National Strategic 
Health Development Plan 2009-2013 (NSHDP) also realized that “the health 
status indicators for Nigeria, starting from infant mortality rate are among the 
worst in the world and that on the average, health status of the population has 
declined, compared to indicators of a decade earlier. Besides general poor health 
status, Nigeria has also huge disparities in health status between geopolitical 
regions and income groups”. 
The questions that now come to mind are: What is the trend of infant mortality 
in Nigeria? Why, despite the huge amount spent on the health sector, the rate 
of infant mortality is still high? Why has the country failed to meet the MDGs 
target of reduction in child mortality by 2/3? Is there any statistically significant 
relationship between government health expenditure and infant mortality rate 
in Nigeria? These and many other reasons prompted the research work with the 
following objectives:
(i) to examine the trend of infant mortality rate;
(ii) to estimate the effects of government health expenditure on infant mortality 
rate in Nigeria; 
(iii) to draw policy implications based on the finding of the study. 
2. STATEMENT OF THE PROBLEM
The World Health Organization (WHO, 2009) has recommended that 15% of the 
total annual budget of the nation should go to the health sector. However, it was 
discovered that a small percentage of the total budget, which is not even up to 
half of WHO’s recommendation, is usually allocated to health sector by Nige-
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rian government. The percentage allocated to health sector was 6.1% in 1996, in 
2002, it dropped to 3.7%. It rose to 9.2% in 2007 while there was a slight drop to 
8.2% in 2014. In 2016 it dropped to 4.23%, whereas in 2017 it slipped to 4.16%. 
In 2018 it dropped drastically to 3.9% which is #340.45b out of #8.6tn. In ad-
dition, it is also worth noting that the country is struggling with several disease 
outbreaks including Monkey pox, Measles and Lassa fever, in addition to efforts 
to end poliomyelitis and tackle the country’s noticeable high mortality and child 
death. 
According to WHO, Nigeria is rated as 187th out of 191 countries of the world in 
terms of health care delivery. Also, one third of more than 700 health facilities 
have been destroyed in the country and about 3.7 million people are in need of 
health assistance. The health body placed Nigeria at third highest in infant mor-
tality rate in the world (healthnews.ng). 
Findings also revealed that health services in Nigeria had suffered decades of 
neglect, resulting in poor health conditions and decreasing national productivity 
(Mathias, Dickson & Bisong, 2013). Although improvements have been record-
ed lately but still fail to meet the MDGs (WHO, 2016) and the need to improve 
health, in order to do this, policy makers have to be guided by knowledge of 
those factors that will drive the health status. Some of these factors include edu-
cation, availability of doctors, immunization taking, etc. This is the reason why 
several researchers have dwelt into this based on the factors mentioned above. 
However, despite all the commendable efforts of these researchers, there are still 
many gaps left unfilled, as it will be revealed under the reviewed literature which 
thus makes this study imperative, in order to fill those gaps and also guide policy 
makers in the right direction.
3. CONCEPTUAL CLARIFICATION
3.1 Health
Health has been defined in different ways by various scholars. According to Dor-
land (1981), it has been defined as “a state of optimal, physical, mental and 
social wellbeing, and not merely absence of disease or infirmity. This definition 
conforms to that of World Health Organization (WHO, 1926:47) which states 
that health is “a state of complete physical, social and mental well-being and 
not merely absence of disease or infirmity”. Nwabuaze (2003) also considers a 
healthy condition as a state of being sound in the body, mind or spirit. Generally 
speaking, the definition of health boils down to being seen as a state of wellness 
and completeness of a person.
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3.2 Infant Mortality Rate (INFM)
The infant mortality rate is the number of deaths of infants under one year of age 
occurring among the live births in a given geographical area during a given year, 
per 1,000 live births occurring among the population of the given geographical 
area during the same year (OECD, 2001; WHO, 2012; Novignon & Lawanson, 
2017). 
3.3 DPT Immunization (DPT)
This is the class of combination of vaccines against three infectious diseases in 
human: Diphtheria, Pertussis and Tetanus. Findings revealed that there exists a 
positive correlation between DPT immunization and fall in infant mortality rates 
(see Murunga, Mogeni & Kimono, 2019; Oluyole & Afeikhna, 2015); this im-
plies that as DPT immunization increases, the IMR should decrease.
3.4 Female Literacy rate (FLR)
This refers to the number of females who are literate (i.e. those who are able to 
read and write); this is proxy by female gross enrolment ratio which is the ratio 
of total enrolment for primary education, regardless of age, to the population of 
the aged group that officially corresponds to the level of education shown. 
4. TREND ANALYSIS OF INFANT MORTALITY RATE IN NIGERIA
The trend analysis shows graphical movement of infant mortality rate in Nigeria 
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Graph 1. Trend of infant mortality rate in Nigeria
Source: Author’s calculation (2020)
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Although INFM experienced a decline from 1990 to date, the trend remains un-
acceptable compared to exploding trend of health sector expenditure. In addi-
tion, the failure of the MDG to meet its target of reducing INFM by 2/3 by the 
end of 2015 as targeted is also a cause for concern. The above scenario therefore 
calls for a re-examination of the established relationship between health care 
expenditure and INFM in Nigeria. 
5. EMPIRICAL REVIEW OF RELATED LITERATURE:  
A SYNOPSIS
Several studies explored the relationship between public health care expenditure 
and health status both in developing and developed countries but there seems to 
be limited studies on Nigeria.
In general, there seems to be some level of inconsistency in the exact relationship 
that exists between government health care expenditure and health outcomes. 
Some studies showed that public health expenditure has no impact on health 
outcome (Santerre, Grubaugh & Stollar, 1991; Kim &Moody, 1992; Musgrave, 
1996; Filmer & Pritchet, 1999; Berger & Messer, 2002; Williamson, 2008; Wil-
son, Gebhard, Kitterman, Mitchell & Nielson, 2009; Kamiya, 2010). Contrary 
to the above, some studies found strong positive relationships between public 
healthcare expenditure and healthcare outcome, and their findings revealed that 
healthcare spending reduces INFM (Nixon & Ulmann, 2006; Murthy & Okun-
ade, 2009; Anyanwu & Erhijakpor, 2009; Rhee, 2012; Farag, Nandakumar, Wal-
lack, Hodgkin, Gaumer & Ebril, 2013; Olaniyan, Onisanwa & Oyinlola, 2013; 
Imougbele & Ismaila, 2013; Bidza, 2015) while studies like Lawanson (2012) 
present a mixed result.
In most of these studies reviewed the presence of female literacy, number of 
doctors and DPT immunization rate were elusive while copious literature ex-
ists on the theme. It should also be noted that most of the work reviewed are 
cross-country in nature while literature on Nigeria is scanty, it is against this 
background that this study sought to fill the vacuum.
6. METHODOLOGY
6.1 Theoretical framework
This study leans on health production function as the theoretical model adopted 
to measure the impact of public health expenditure on health outcome in Nige-
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ria. These production functions include the application of the economic concept 
of a production function in the field of health services. The health production 
function specifies the relationship between government expenditure on health 
and health status and helps to determine which input produces a single output on 
health status.
This study considered Grossman (1972) model which envisages that individual 
health status is a function of individual inputs and is specified as shown below 
Y = f (X )  (i)
where Y is a measure of individual health status (IFMR) and X is a measure 
of inputs to the health function (GDPPC, 
pubexp
GDP , FLR, Immunization, Z); Z 
here is other explanatory variable introduced which is not captured by Grossman 
(1972) and here represented the number of doctors per 1000 patients. 
6.2 Sources of Data and Data requirements
This research work used data covering the period 1991-2018 in the empirical 
analysis.







+ β3DOCt + β4FLRt + β5DPTt + µt  (ii)
where
INFM = Infant mortality rate
GDPPC = Gross Domestic Product Per Capita




) = Total government expenditure on health as a fraction of the GDP 
(henceforth written as PUBEXP for analytical convenience)
FLR = Female Literacy Rate
DPT = Diphtheria, Pertussis (whopping cough), and Tetanus immunization.
On a priori, β1 − β5  are expected to be < 0
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6.3 Presentation and discussion of results
This section presents the statistical estimates and empirical results from the esti-
mations of the model.
6.3.1 Descriptive Statistics
The result of the descriptive statistics computation is presented in Table 1 below:
Table 1. Descriptive statistics results
INFM GDPPC PUBEXP FLR DOC DPT
Mean 99.39 281593.5 4.36 43.13 153.89 40.07
Median 97.10 274232.8 4.59 43.32 150.65 41.00
Maximum 124.90 385349.0 9.45 52.66 208.80 63.00
Minimum 75.70 202704.0 0.91 41.39 107.30 21.00
Std. Dev. 17.81 68375.68 3.06 2.16 31.57 11.32
Skewness 0.16 0.213 0.36 3.05 0.19 0.28
Kurtosis 1.47 1.43 1.64 14.73 1.76 2.12
Jarque-Bera 2.85 3.10 2.78 203.78 1.97 1.28
Probability 0.24 0.21 0.25 0.00 0.37 0.53
Sum 2782.8 7884617. 122.17 1207.885 4309.00 1122.00
Sum Sq. Dev. 8561.1 1.26E+11 252.6 125.633 26915.18 3461.86
Observations 28 28 28 28 28 28
Source: Author’s calculation (2020)
Table 1 above shows that all the series display a high level of consistency as 
their mean and median values are perpetually within the minimum and maxi-
mum values of these series. Moreover, the standard deviation which measures 
the level of variation of the variable from their mean is relatively low for most 
of the series indicating that the deviations of actual data from their mean values 
are very small. The table also reveals that the mean value of INFM, GDPPC and 
DOC are greater than their respective median values which suggests that the 
variables are positively skewed, while the mean value of PUBEXP, DPT and 
FLR are less than their respective median values suggesting that the variables are 
negatively skewed. This positive and negative skewness are formally confirmed 
by the skewness statistics for the variables. The wide ranges suggest that all the 
variables exhibit high variations in their distributions. 
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6.3.2 Correlation matrix
In order to have a preliminary idea of the direction of relationship between the 
variables, the correlation matrix of dependent and independent variables is com-
puted. This is reported below.
Table 2. Correlation matrix
INFM GDPPC PUBEXP DPT DOC FLR
INFM Pearson Correlation 1
Sig. (2-tailed)
N 28
GDPPC Pearson Correlation -.954** 1
Sig. (2-tailed) .000
N 28 28
PUBEXP Pearson Correlation -.812** .814** 1
Sig. (2-tailed) .000 .000
N 28 28 28
DPT Pearson Correlation -.690** .749** .710** 1
Sig. (2-tailed) .000 .000 .000
N 28 28 28 28
DOC Pearson Correlation -.980** .954** .728** .685** 1
Sig. (2-tailed) .000 .000 .000 .000
N 28 28 28 28 28
FLR Pearson Correlation .207 -.266 -.381* -.129 -.132 1
Sig. (2-tailed) .291 .172 .045 .514 .503
N 28 28 28 28 28 28
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
Source: Author’s calculation (2020)
From the table, the correlation of INFM with GDPPC has a coefficient of -0.954, 
with a p-value of 0.000 meaning that an increase in GDPPC will reduce INFM 
and it is statistically significant. Also, its correlation with PUBEXP has a coeffi-
cient of -0.812 with a p-value of 0.000 meaning that the coefficient is statistically 
significant and an increase in it brings a fall in INFM.
DPT which is another variable considered to have effect on INFM shows a nega-
tive coefficient of -0.690 with a p-value of 0.000 implying a negative statistically 
significance. On the other hand, coefficient of FLR presents a positive value of 
0.207 with a p-value of 0.291 indicating that it has positive coefficient that is sta-
tistically not significant. Finally, its correlation coefficient with DOC is -0.980 
with a p-value of 0.000. This implies that an increase in DOC will cause INFM 
to fall and it is statistically significant.
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The second column shows that GDPPC is positively correlated with PUBEXP, 
DPT and DOC and statistically significant except for FLR with which it has a 
negative and non-statistically significant relationship. The third column displays 
the coefficient of correlation between PUBEXP and FLR to be negative and sig-
nificant at 5% while it presents a positive and significant coefficient with DPT 
and DOC. The fourth column shows a negative and non-significant value with 
FLR while it has positive and significant correlation with DOC. The last column 
shows a negative and non-significant value with FLR. However, care must be 
taken while interpreting the correlation matrix because they cannot provide a 
valuable indicator of association in a manner which controls additional explana-
tory variables, hence there is a need for other robustness checks.  
6.3.3 Unit root test Result
The results of the unit root test for the variables used in the study based on Aug-
mented Dickey Fuller (ADF) unit root test procedure (with constant and trend) 
to see whether the variables are significant at level, i.e. whether it is I(0) series, 
or at first difference, i.e. whether it is I(1) series, are presented in Table 3 below. 
Table 3. Unit Root Test Results







INFM 4.414*** 3.711 2.981 2.630 I(0)
GDPPC 1.839* 2.755 1.971 1.604 I(1)
PUBEXP 3.999** 4.004 3.099 2.690 I(0)
FLR 4.120*** 3.920 3.066 2.673 I(1)
DPT 5.601*** 3.711 2.981 2.630 I(1)
DOC 3.889*** 3.724 2.986 2.632 I(1)
***denotes significant at 1%, ** denotes significant at 5%, * denotes significant at 10%. 
Source: Author’s computation (2020) using E-view 9
The unit root test is carried out with intercept specifications for the respective 
series since it is a single variable and it is also the default that comes with the 
E-view. The lag-selection was based on the default selection of the Newey-West 
Bandwidth (NWB). The table contains the ADF test statistic at levels and levels 
and intercept of the time series with the null hypothesis which states that there 
is no unit root. The result based on 1% significant level shows the orders of 
integration of the variables, being stationary at levels and levels and intercept. 
In particular, the stationarity of the general unit root process for the set of time 
series data for the variables shows that they are all significant at 1 % except for 
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GDPPC which is significant at 10%. Thus the null hypothesis of unit root in the 
data can be upheld. 
6.3.4 Long Run Relationship between the Variables
Co-integration is carried out based on test proposed by Johansen. Below is the 
test result: 
Table 4. Long Run Relationship between the Variables
Series: INFM GDPPC PUBEXP FLR DPT DOC 
Lags interval (in first differences): 1 to 1
Unrestricted Cointegration Rank Test (Trace)
Hypothesized Trace 0.05
No. of CE(s) Eigenvalue Statistic Critical Value Prob.**
None *  0.900  173.472  95.754  0.000
At most 1 *  0.861  113.476  69.819  0.000
At most 2 *  0.698  62.129  47.856  0.001
At most 3 *  0.503  30.991  29.797  0.036
At most 4  0.389  12.816  15.495  0.121
At most 5  0.000  0.010  3.841  0.920
 Trace test indicates 4 cointegrating eqn(s) at the 0.05 level
 * denotes rejection of the hypothesis at the 0.05 level
 **MacKinnon-Haug-Michelis (1999) p-values
Unrestricted Co-integration Rank Test (Maximum Eigenvalue)
Hypothesized Max-Eigen 0.05
No. of CE(s) Eigenvalue Statistic Critical Value Prob.**
None *  0.90  59.99  40.08  0.00
At most 1 *  0.86  51.35  33.88  0.00
At most 2 *  0.70  31.14  27.58  0.02
At most 3  0.50  18.18  21.13  0.12
At most 4  0.39  12.81  14.27  0.08
At most 5  0.00  0.01  3.84  0.92
 Max-eigenvalue test indicates 3 co-integrating eqn(s) at the 0.05 level
 * denotes rejection of the hypothesis at the 0.05 level
 **MacKinnon-Haug-Michelis (1999) p-values
Source: Author’s computation (2020) using E-view 9
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As evident in the table above, the co-integration tests included the INFM, GDP-
PC, PUBEXP, FLR, DOC and DPT. The trace test and the maximum Eigenvalue 
statistics show the existence of four (4) and three (3) integrating equation respec-
tively between INFM and the variables influencing it at 5% level of significance. 
The implication of this result is that there exists a unique long run relationship 
between INFM and GDPPC, PUBEXP, FLR, DOC and DPT. 
6.3.5 Robustness and diagnostic test results
This study performs an auxiliary regression using the residuals from the origi-
nal equation since it is conventionally believed that the conventional computed 
standard errors are no longer valid even with the consistency of OLS estimates in 
the presence of heteroscedasticity. Thus there is a need to test for heteroscedastic-
ity in a formal way in this study by applying Breusch-Pagan-Godfrey approach. 
The test is conducted using the probability value with the decision rule that we 
accept the null hypothesis if the p-value is less than 5% and reject if otherwise 
with conclusion that there is no heteroscedasticity. The result is presented below: 
Table 5. Heteroscedasticity Test: White
Heteroscedasticity Test: Breusch-Pagan-Godfrey
F-statistic 1.65     Prob. F(6,20) 0.19
Obs*R-squared 8.93     Prob. Chi-Square(6) 0.18
Scaled explained SS 5.06     Prob. Chi-Square(6) 0.54
Source: Author’s computation
From Table 5 above, R2 value is 8.93 and resulting Chi-square is 0.18, implying 
that the probability value is greater than 5% significant level, thus we reject the 
null hypothesis and conclude that there is no heteroscedasticity in the model.
Table 6. Serial Correlation Test
Breusch-Godfrey Serial Correlation LM Test:
F-statistic 20.51     Prob. F(1,19) 0.0002
Obs*R-squared 14.02     Prob. Chi-Square(1) 0.0002
Source: Author’s computation (2020)
This study employed Breusch Godfrey serial Correlation Langranger Multiplier 
test, and the result revealed that null hypothesis of serial correlation is rejected. 
This shows that the model is free from the problem of autocorrelation. However, 
to ensure that the model is free from multicollinearity problems the study con-
ducts the Variance Inflation Factor (VIF) test, the result of which is presented 
below.
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Table 7. Variance Inflation Factor (VIF) test
Variance Inflation Factors: INFM




Variable Variance VIF VIF
PUBEXP  0.074  76.16  2.67
GDPPC  1.10E-1  11.57  7.37
FLR  0.802  3853.3  2.33
DPT  0.002  88.62  6.64
DOC  0.001  425.36  19.84
C  199.49  4662.5  NA
Source: Author’s computation (2020)
As presented in Table 7, it was revealed that the model is free from multicol-
linearity as each of the centered VIF of the variables is below 20 above which a 
variable is considered as having linear relationship with another variable. 
6.3.6 Regression Result
Having evaluated the general diagnostic statistics above, we can now proceed 
below to examine the performance of each explanatory variable from the regres-
sion result
Table 8. Fully Modified Least Squares (FMOLS)
Method: Fully Modified Least Squares (FMOLS)
Date: 01/03/20  Time: 09:57
Sample (adjusted): 1992 2018
Included observations: 27 after adjustments
Cointegrating equation deterministics: C
Long-run covariance estimate (Bartlett kernel, Newey-West fixed bandwidth = 3.0000)
Variable Coefficient Std. Error t-Statistic Prob.  
LOG(GDPPC) -3.18 6.61 -0.48 0.64
PUBEXP -1.24 0.23 -5.51 0.00
FLR 0.07 0.18 0.41 0.69
DPT 0.11 0.05 2.39 0.03
DOC -0.47 0.04 -10.98 0.00
C 208.53 78.69 2.65 0.02
R-squared 0.98     Mean dependent var 98.44
Adjusted R-squared 0.98     S.D. dependent var 17.42
S.E. of regression 2.64     Sum squared resid 146.06
Long-run variance 2.87
Source: Author’s computation (2020) 
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Table 8 above presented the Fully-Modified co-integration regression on INFM 
in Nigeria. It was revealed that GDPPC has an inverse effect on INFM, thus a 
1%-point increase in GDPPC reduces INFM by 3.2 units. This led credence to 
Grossman theory which states that good health status is a positive function of 
individual income level. Although the result is not significant even at 10% this 
justifies the notion that an increase in income per capita does not necessarily im-
ply improvement in INFM in Nigeria as considered in this study. This problem 
could be traced to the widening gap in income among all levels of citizens in 
the country. This suggests that the government should concentrate on its income 
redistribution role so as to bridge the gap and enhance the significance of per 
capita income on improving INFM to meet the Sustainable Development Goal 
target of Reducing Infant Mortality by 2/3.
In the case of doctors per 1000 population, findings revealed that every addition-
al doctor employed reduces INFM by 0.5 units. PUBEXP also showed a negative 
sign and was found to be significant at 1% significant level; a unit rise in PU-
BEXP tends to reduce INFM by 1.2units. DPT immunization presents a positive 
sign as against the a priori expectation. Perhaps, these could be attributed to poor 
sensitization and corruption in the procurement of the required vaccines and also 
in the administration of the programmes.
FLR also presents a positive sign and insignificant even at 10%. This might be 
due to the current trend of literate female devoting more time to work at the 
expense of their home leaving the care of their baby at early days to day care 
operators and the whim and caprice of nannies.
The reported R-squared of the model shows that the model explains about 98.1% 
of variations in INFM in Nigeria. The adjusted R-squared also showed a value 
of 97.7 % which means that other variable outside the model only covered about 
2.3% and most variables included are significant, which showed that the model 
is a good fit.
7. COMPARISON OF THE STUDY WITH PREVIOUS  
EMPIRICAL STUDIES REVIEWED
Summarily, the findings of this study are in conformity with Santere, Grubaugh 
and Stollar (1991) as well as with Berger and Messer (2002), whose findings also 
revealed that PUBEXP is unable to reduce INFM while it is against other stud-
ies (Rhee, 2012; Farag, et al. 2013; Bizda, 2015) whose findings revealed that 
PUBEXP reduces INFM. However, it should be noted that all reviewed studies 
whose findings contradict our findings are either cross country in nature or not 
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carried out specifically on Nigeria and what is obtained in these countries may 
not be applicable to the situation in Nigeria. 
8. SUMMARY, CONCLUSION AND RECOMMENDATIONS
Alluding to the fact that the pattern of financing is closely and indivisibly linked 
to the quality of health outcomes most especially in developing world (Nigeria 
inclusive), which over the years has necessitated increased spending on the sec-
tor. The result of the spending has generated controversy among scholars making 
some believe it is non-productive as expected, while others are against this no-
tion. The mixed believe calls for this study which examined the effect of public 
health expenditure on INFM factoring in other explanatory variables, such as 
FLR, DPT immunization, GDPPC, and DOC, which are considered capable of 
hindering the desired outcome of increased government spending on infant mor-
tality rate. Summarily, findings revealed that all variables positively impacted 
INFM except for DPT and FLR and possible reasons were adduced for that. 
Based on the findings of this study the following recommendations are proffered 
if Nigerian health status (INFM) is to improve and build a virile labour force 
capable of moving the nation towards development.
 – Government should intensify efforts by increasing the percentage of its 
allocation to heath sector to make it reach the suggested percentage from 
the country’s annual budget by WHO.
 – Government should endeavor to reduce income inequality among citizens 
through its redistributive role so that GDPPC has a statistically significant 
impact on the reduction of INFM in Nigeria. 
 – Findings should be made on why DPT immunization failed to produce the 
desired outcome and proffer solution.
 – More public enlightenments on the importance of taking DPT immuniza-
tion for infants should be embarked upon for the target audience to be able 
to produce a positive effect.
 – Nursing mothers should be educated more on the need to take good care of 
their children especially at the early stage and not leave chance to the faith 
of the day care all in the name of being literate and answering the call of 
their job at the expense of their parental role. 
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ПОТРОШЊА НА ЈАВНО ЗДРАВСТВО И СТОПА 
СМРТНОСТИ НОВОРОЂЕНЧАДИ У НИГЕРИЈИ
1 Адеагбо Метју Олувасеун , Факултет умјетности и друштвених наука 
Колеџ за образовање, Ланлате, држава Ојо
САЖЕТАК
Једна од бројних одговорности владе било које земље јесте улагање у ра-
зличите секторе привреде. Међутим, улагање би требало да се усмјери у 
одговарајуће секторе, попут здравственог, који ће довести до континуира-
ног раста земље. У свјетлу овога, ова студија разматра државну потрошњу 
на здравствени сектор и њен утицај на стопу смртности новорођенчади у 
Нигерији. Здравље је најважније за добробит грађана. Ова студија је поку-
шала да пружи емпиријске доказе о утицају потрошње на јавно здравство 
на стопу смртности новорођенчади у Нигерији између 1991. и 2018. године 
користећи податке из временских серија. За испитивање односа коришћена 
је аналитичка метода потпуно модификованих обичних најмањих квадрата. 
Извршене су разне провјере робусности како би се креаторима политика 
обезбиједила поузданост резултата. Резултати су открили да су све прими-
јењене варијабле позитивно утицале на стопу смртности новорођенчади, 
осим имунизације против дифтерије, пертусиса и тетануса (ДПТ), и сто-
пе писмености жена. Стога је препоручено да се приступи већем јавном 
просвјетљењу о важности ДПТ имунизације за новорођенчад како би циљ-
на публика могла да произведе позитиван ефекат, дојиље би требало више 
едуковати о потреби добре бриге о својој деци посебно у раним годинама и 
непрепуштању бриге другима због описмењавања и одласка на посао, а на 
штету њихове родитељске улоге.
Кључне ријечи: 
потрошња на јавно здравство, стопа смртности новорођенчади, писменост 
жена, дифтерија, пертусис и тетанус.
